Observational studyJournal of interventional cardiology2019
Transcatheter Atrial Septal Defect Closure in Children with and without Fluoroscopy: A Comparison.
Observational study in Journal of interventional cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Percutaneous Zero-fluoroscopy Atrial Septal Defect ClosureCurrent cardiology reviews · 2026Pooled it
- Complications after percutaneous device closure of atrial septal defects in children: Prevalence, outcomes and associated factors.International journal of cardiology. Congenital heart disease · 2026Article
- Atrial Septal Aneurysms: The Heart's Hidden Bulge.Acta Cardiologica Sinica · 2026Review
- Comparison of Sizing Methods to Optimize Device Selection for Percutaneous Closure of Atrial Septal Defects.Cardiology research and practice · 2026Article
- Fluoroscopy-free Transcatheter Atrial Septal Defect Closure: A Simplified Approach.Current cardiology reports · 2025Review
- Expanding role of absolute zero fluoroscopy atrial septal defect closure: a single-center experience.Frontiers in cardiovascular medicine · 2025Article
- Percutaneous atrial septal defect closure in limited-resource setting: a decade-long experience from Ethiopia.Frontiers in cardiovascular medicine · 2025Article
- Emergency Bedside Transoesophageal Echocardiography-guided Atrial Septal Defect Closure Without Fluoroscopy after Left Ventricular Assist Device Implantation.Interventional cardiology (London, England) · 2025Article
- Echocardiography-guided percutaneous closure of oval-shaped secundum atrial septal defects.BMC cardiovascular disorders · 2024Article
- Zero to minimal fluoroscopy for cardiac electronic device implantation: A systematic review and meta-analysis.Journal of arrhythmia · 2024Article
- A novelMolecular medicine reports · 2022Article
- Review
- Combined Echo and Fluoroscopy-Guided Pulmonary Valvuloplasty in Neonates and Infants: Efficacy and Safety.Pediatric cardiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe aim of this study was to compare feasibility, effectiveness, safety, and outcome of atrial septal defect (ASD) device closure in children with and without fluoroscopy guidance. METHODS AND
resultsChildren undergoing transcatheter ASD closure between 2002 and 2016 were included into this single center, retrospective study. Patients were analysed in two groups [1: intraprocedural fluoroscopy ± transoesophageal echocardiography (TOE) guidance; 2: TOE guidance alone]. Three-hundred-ninety-seven children were included, 238 (97 male) in group 1 and 159 (56 male) in group 2. Two-hundred-twenty-nine of 238 (96%) patients underwent successful fluoroscopy guided ASD closures versus 154/159 (97%) successful procedures with TOE guidance alone. Median weight (IQR) at intervention was 20kg (16.0-35.0) in group 1 versus 19.3kg (16.0-31.2) in group 2. Mean (SD) preinterventional ASD diameter was 12.4mm (4.4) in group 1 versus 12.2mm (3.9) in group 2. There was no significant difference in number of defects or characteristics of ASD rims. Median procedure time was shorter in group 2 [60min (47-86) versus 34min (28-44)]. Device-size-to-defect-ratio was similar in both groups [group 1: 1.07 versus group 2: 1.09]. There were less technical intraprocedural events in group 2 [10 (6.3%) versus 47 (20%)]. Intraprocedural complications were less frequent in group 2 [1 (0.6%) versus 8 (3.3%)].
conclusionTranscatheter ASD device closure with TOE guidance alone (i.e., without fluoroscopy) is as effective and safe as ASD closure with fluoroscopy guidance. As fluoroscopy remains an important adjunct to transoesophageal echocardiography, especially in complex defects and complications, procedures are always performed in a fully equipped cardiac catheterization laboratory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.